Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.01
+0.25 (4.25%)
Oct 8, 2025, 11:49 AM EDT - Market open
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $373.03 million as of October 8, 2025. Its market cap has decreased by -22.40% in one year.
Market Cap
373.03M
Enterprise Value
198.61M
1-Year Change
-22.40%
Ranking
Category
Stock Price
$6.01
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $373.03M, a decrease of -6.21%. That is a compound annual growth rate of -1.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 367.75M | -10.44% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 760.72B |
| Johnson & Johnson | 452.70B |
| AbbVie | 403.43B |
| UnitedHealth Group | 325.88B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 233.19B |